Inhibikase Therapeutics, Inc. (IKT): SCHEDULE 13G filed Jul 17, 2026

Form type

SCHEDULE 13G

Filing date

Jul 17, 2026

Accession number

0001346824-26-000193

Filer

Inhibikase Therapeutics, Inc. (CIK 1750149)